Quantitative imaging of coronary blood flow

Adam M. Alessio received his PhD in Electrical Engineering from the University of Notre Dame in 2003. During his graduate studies he developed tomographic reconstruction methods for correlated data and helped construct a high-resolution PET system. He is currently a Research Assistant Professor in Radiology at the University of Washington. His research interests focus on improved data processing and reconstruction algorithms for PET/CT systems with an emphasis on quantitative imaging. Erik Butterworth recieved the BA degree in Mathematics from the University of Chicago in 1977. Between 1977 and 1987 he worked as a computer programmer/analyst for several small commercial software firms. Since 1988, he has worked as a software engineer on various research projects at the University of Washington. Between 1988 and 1993 he developed a real-time data aquisition for the analysis of estuarine sediment transport in the department of Geophysics. Between 1988 and 2002 he developed I4, a system for the display and analysis of cardic PET images in the department of Cardiology. Since 1993 he has worked on physiological simulation systems (XSIM from 1993 to 1999, JSim since 1999) at the National Simulation Resource Facility in Cirulatory Mass Transport and Exchange, in the Department of Bioengineering. His research interests include simulation systems and medical imaging. James H. Caldwell, MD, University of Missouri-Columbia 1970, is Professor of Medicine (Cardiology) and Radiology and Adjunct Professor of Bioengineering at the University of Washington School of Medicine and Acting Head, Division of Cardiology and Director of Nuclear Cardiology for the University of Washington Hospitals, Seattle WA, USA. James B. Bassingthwaighte, MD, Toronto 1955, PhD Mayo Grad Sch Med 1964, was Professor of Physiology and of Medicine at Mayo Clinic until 1975 when he moved to the University of Washington to chair Bioengineering. He is Professor of Bioengineering and Radiology. In 1979, he established a National Simulation Resource Facility in Circulatory Mass Transport and Exchange and in 1997, he initiated the Human Physiome Projects. He is a member of the US National Academy of Engineering. His research is on quantitative integration of cellular and cardiovascular systems. Positron emission tomography (PET) is a nuclear medicine imaging modality based on the administration of a positron-emitting radiotracer, the imaging of the distribution and kinetics of the tracer, and the interpretation of the physiological events and their meaning with respect to health and disease. PET imaging was introduced in the 1970s and numerous advances in radiotracers and detection systems have enabled this modality to address a wide variety of clinical tasks, such as the detection of cancer, staging of Alzheimer's disease, and assessment of coronary artery disease (CAD). This review provides a description of the logic and the logistics of the processes required for PET imaging and a discussion of its use in guiding the treatment of CAD. Finally, we outline prospects and limitations of nanoparticles as agents for PET imaging.

[1]  Eric D. Pressly,et al.  Synthesis and characterization of core-shell star copolymers for in vivo PET imaging applications. , 2008, Biomacromolecules.

[2]  M E Phelps,et al.  Quantitation in Positron Emission Computed Tomography: 6. Effect of Nonuniform Resolution , 1982, Journal of computer assisted tomography.

[3]  R. Dannals,et al.  Characterization of uptake of the new PET imaging compound 18F-fluorobenzyl triphenyl phosphonium in dog myocardium. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  J B Bassingthwaighte,et al.  Molecular and particulate depositions for regional myocardial flows in sheep. , 1990, Circulation research.

[5]  Josef Machac,et al.  Cardiac positron emission tomography imaging. , 2005, Seminars in nuclear medicine.

[6]  L. Shaw,et al.  Comparison of accuracy for detecting coronary artery disease and side-effect profile of dipyridamole thallium-201 myocardial perfusion imaging in women versus men. , 1992, The American journal of cardiology.

[7]  M. Glas,et al.  Principles of Computerized Tomographic Imaging , 2000 .

[8]  N. Mullani,et al.  Coronary flow and flow reserve by PET simplified for clinical applications using rubidium-82 or nitrogen-13-ammonia. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  R. Weissleder,et al.  Cell-specific targeting of nanoparticles by multivalent attachment of small molecules , 2005, Nature Biotechnology.

[10]  G Germano,et al.  Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. , 1995, Journal of the American College of Cardiology.

[11]  S. Cherry,et al.  Physics in Nuclear Medicine , 2004 .

[12]  M. Bawendi,et al.  Renal clearance of quantum dots , 2007, Nature Biotechnology.

[13]  Capillary and cell wall permeability to potassium in isolated dog hearts. , 1974, The American journal of physiology.

[14]  M E Phelps,et al.  Effect of positron range on spatial resolution. , 1975, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  M E Phelps,et al.  Rabbit myocardial 82Rb kinetics and a compartmental model for blood flow estimation. , 1989, The American journal of physiology.

[16]  Thomas Beyer,et al.  X-ray-based attenuation correction for positron emission tomography/computed tomography scanners. , 2003, Seminars in nuclear medicine.

[17]  D. Berman,et al.  Incremental prognostic value of adenosine stress myocardial perfusion single-photon emission computed tomography and impact on subsequent management in patients with or suspected of having myocardial ischemia. , 1997, The American journal of cardiology.

[18]  H. Malcolm Hudson,et al.  Accelerated image reconstruction using ordered subsets of projection data , 1994, IEEE Trans. Medical Imaging.

[19]  J B Bassingthwaighte,et al.  A Concurrent Flow Model for Extraction during Transcapillary Passage , 1974, Circulation research.

[20]  Keiichiro Yoshinaga,et al.  What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? , 2006, Journal of the American College of Cardiology.

[21]  D. Berman,et al.  Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: what is the warranty period of a normal scan? , 2003, Journal of the American College of Cardiology.

[22]  E. Kim PET and PET/CT: A Clinical Guide , 2010, Journal of Nuclear Medicine.

[23]  James A. Scott,et al.  Positron Emission Tomography: Basic Science and Clinical Practice , 2004 .

[24]  H. Atkins,et al.  Emission tomography. , 1979, New York state journal of medicine.

[25]  K H Ephraïm,et al.  [Nuclear medicine. I]. , 1979, Tijdschrift voor ziekenverpleging.

[26]  J van den Hoff,et al.  [1-(11)C]Acetate as a quantitative perfusion tracer in myocardial PET. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  H. Primakoff,et al.  On the Angular Distribution of Two-Photon Annihilation Radiation , 1950 .

[28]  Eric D. Pressly,et al.  Structural effects on the biodistribution and positron emission tomography (PET) imaging of well-defined (64)Cu-labeled nanoparticles comprised of amphiphilic block graft copolymers. , 2007, Biomacromolecules.

[29]  C. Bohm,et al.  Correction for Scattered Radiation in a Ring Detector Positron Camera by Integral Transformation of the Projections , 1983, Journal of computer assisted tomography.

[30]  P. Herrero,et al.  Implementation and evaluation of a two-compartment model for quantification of myocardial perfusion with rubidium-82 and positron emission tomography. , 1992, Circulation research.

[31]  D E Kuhl,et al.  Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. , 1990, Journal of the American College of Cardiology.

[32]  M J Welch,et al.  Quantification of regional myocardial blood flow in vivo with H2150* , 2005 .

[33]  Greg M Thurber,et al.  18F labeled nanoparticles for in vivo PET-CT imaging. , 2009, Bioconjugate chemistry.

[34]  Michael E Casey,et al.  PET performance measurements using the NEMA NU 2-2001 standard. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[35]  J. Bassingthwaighte,et al.  Circulatory Transport of Iodoantipyrine and Water in the Isolated Dog Heart , 1970, Circulation research.

[36]  N. Freedman,et al.  SPECT Attenuation Artifacts in Normal and Overweight Persons: Insights from a Retrospective Comparison of Rb-82 Positron Emission Tomography and Tl-201 SPECT Myocardial Perfusion Imaging , 2000, Clinical nuclear medicine.

[37]  J R Stratton,et al.  Quantitation of size of relative myocardial perfusion defect by single-photon emission computed tomography. , 1984, Circulation.

[38]  E. M. Renkin,et al.  Exchangeability of tissue potassium in skeletal muscle. , 1959, The American journal of physiology.

[39]  H. Jadvar,et al.  SPECT and PET in the evaluation of coronary artery disease. , 1999, Radiographics : a review publication of the Radiological Society of North America, Inc.

[40]  R. deKemp,et al.  Will 3-dimensional PET-CT enable the routine quantification of myocardial blood flow? , 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[41]  J B Bassingthwaighte,et al.  Regional Distribution of Diffusible Tracers and Carbonized Microspheres in the Left Ventricle of Isolated Dog Hearts , 1973, Circulation research.

[42]  O Muzik,et al.  Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[43]  Paul Kinahan,et al.  A combined PET/CT scanner for clinical oncology. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[44]  E. Hoffman,et al.  Quantitation in Positron Emission Computed Tomography: 4. Effect of Accidental Coincidences , 1981, Journal of computer assisted tomography.

[45]  J. M. Ollinger,et al.  Detector efficiency and Compton scatter in fully 3D PET , 1994, Proceedings of 1994 IEEE Nuclear Science Symposium - NSS'94.

[46]  M. Verani,et al.  Quantitative thallium-201 single-photon emission computed tomography during maximal pharmacologic coronary vasodilation with adenosine for assessing coronary artery disease. , 1991, Journal of the American College of Cardiology.

[47]  H. J. Lamb,et al.  Diagnostic and prognostic value of non-invasive imaging in known or suspected coronary artery disease , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[48]  J. Bassingthwaighte,et al.  Modeling [15O]oxygen tracer data for estimating oxygen consumption. , 1996, The American journal of physiology.

[49]  W. N. Tauxe,et al.  Albumin macroaggregates and measurements of regional blood flow: validity and application of particle sizing by Coulter counter. , 1970, Journal of Laboratory and Clinical Medicine.

[50]  O. Muzik,et al.  Assessment of myocardial perfusion by dynamic N-13 ammonia PET imaging: Comparison of 2 tracer kinetic models , 2005, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[51]  David W. Townsend,et al.  Positon emission tomography: basic science and clinical practice , 2008 .

[52]  Xinrong Liu,et al.  Cell Culture and Xenograft-Bearing Animal Studies of Radiolabeled Antisense DNA–Carrier Nanoparticles with Streptavidin as a Linker , 2007, Journal of Nuclear Medicine.

[53]  Shankar Vallabhajosula,et al.  (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization. , 2007, Seminars in nuclear medicine.

[54]  C. Hawker,et al.  The Advantages of Nanoparticles for PET , 2009, Journal of Nuclear Medicine.

[55]  Ralph Weissleder,et al.  Nanoparticle PET-CT Imaging of Macrophages in Inflammatory Atherosclerosis , 2008, Circulation.

[56]  M E Phelps,et al.  13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography. , 1989, Circulation.

[57]  Zahi A Fayad,et al.  Nanotechnology in Medical Imaging: Probe Design and Applications , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[58]  John D Friedman,et al.  Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: Comparison with ECG-gated Tc-99m sestamibi SPECT , 2006, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[59]  C. Crone,et al.  THE PERMEABILITY OF CAPILLARIES IN VARIOUS ORGANS AS DETERMINED BY USE OF THE 'INDICATOR DIFFUSION' METHOD. , 1963, Acta physiologica Scandinavica.

[60]  D. Berman,et al.  Diffuse slow washout of myocardial thallium-201: a new scintigraphic indicator of extensive coronary artery disease. , 1984, Journal of the American College of Cardiology.